Literature DB >> 33649294

The long noncoding RNA TINCR promotes breast cancer cell proliferation and migration by regulating OAS1.

Die Lu1, Shihao Di1, Shuaishuai Zhuo1, Linyan Zhou2, Rumeng Bai1, Tianshi Ma1,3, Zigui Zou1,4, Chunni Chen1, Miaomiao Sun1, Jinhai Tang5, Zhihong Zhang6.   

Abstract

Breast cancer is the leading cause of cancer-related death in women around the world. It is urgently needed to identify genes associated with tumorigenesis and prognosis, as well as to elucidate the molecular mechanisms underlying the oncogenic process. Long noncoding RNAs (lncRNAs) are widely involved in the pathological and physiological processes of organisms and play an important role as oncogenes or tumor suppressor genes, affecting the development and progression of tumors. In this study, we focused on terminal differentiation-induced non-coding RNA (TINCR) (GeneID:257000) and explore its role in the pathogenesis of breast cancer. The results showed that TINCR was increased in breast cancer tissue, and high expression level of TINCR was associated with older age, larger tumor size, and advanced TNM stage. High level of TINCR can promote proliferation and metastasis of breast cancer cells, while downregulation of TINCR induces G1-G0 arrest and apoptosis. Mechanismly, TINCR can bind to staufen1 (STAU1) and then guide STAU1 (GeneID:6780) to bind to OAS1 mRNA (NM_016816.4) to mediate its stability. Thus low level of OAS1(GeneID:4938) can lead to cell proliferation and migration. This result elucidates a new mechanism for TINCR in breast cancer development and provides a survival indicator and potential therapeutic target for breast cancer patients.

Entities:  

Year:  2021        PMID: 33649294     DOI: 10.1038/s41420-021-00419-x

Source DB:  PubMed          Journal:  Cell Death Discov        ISSN: 2058-7716


  12 in total

1.  Ferroptosis-Related Long Noncoding RNAs as Prognostic Biomarkers for Ovarian Cancer.

Authors:  Kaili Wang; Shanshan Mei; Mengcheng Cai; Dongxia Zhai; Danying Zhang; Jin Yu; Zhexin Ni; Chaoqin Yu
Journal:  Front Oncol       Date:  2022-06-09       Impact factor: 5.738

Review 2.  LINC00261: a burgeoning long noncoding RNA related to cancer.

Authors:  Menggang Zhang; Fang Gao; Xiao Yu; Qiyao Zhang; Zongzong Sun; Yuting He; Wenzhi Guo
Journal:  Cancer Cell Int       Date:  2021-05-22       Impact factor: 5.722

3.  Development of a Prognostic Model Based on the Identification of EMT-Related lncRNAs in Triple-Negative Breast Cancer.

Authors:  Jiani Guo; Xuesong Yi; Zhuqing Ji; Mengchu Yao; Yu Yang; Wei Song; Mingde Huang
Journal:  J Oncol       Date:  2021-11-27       Impact factor: 4.375

4.  Upregulation of ADAR Promotes Breast Cancer Progression and Serves as a Potential Therapeutic Target.

Authors:  Xiao Li; Guangshun Sun; Liangliang Wu; Guoqiang Sun; Ye Cheng; Jing Tao; Zhouxiao Li; Weiwei Tang; Hanjin Wang
Journal:  J Oncol       Date:  2021-09-27       Impact factor: 4.375

5.  Role of AUF1 in modulating the proliferation, migration and senescence of skin cells.

Authors:  Daojiang Yu; Xiaoqian Li; Zhenyu Wang; Sheng Jiang; Tao Yan; Kai Fang; Yuhong Shi; Zhiqiang Jiang; Shuyu Zhang
Journal:  Exp Ther Med       Date:  2021-11-14       Impact factor: 2.447

Review 6.  Blood Circulating Non-Coding RNAs for the Clinical Management of Triple-Negative Breast Cancer.

Authors:  Tomasz Powrózek; Michael Ochieng Otieno
Journal:  Cancers (Basel)       Date:  2022-02-04       Impact factor: 6.639

7.  Long non-coding RNA (LncRNA) SNHG7/ Eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) involves in the malignant events of ovarian cancer cells with paclitaxel resistant.

Authors:  Jin Zhang; Rui Zhang; Yongju Ye
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 8.  The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression.

Authors:  Lu Xia; Jingyun Chen; Min Huang; Jie Mei; Min Lin
Journal:  Front Oncol       Date:  2022-07-19       Impact factor: 5.738

9.  Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer.

Authors:  Lingling Lu; Huaxiang Wang; Jian Fang; Jiaolong Zheng; Bang Liu; Lei Xia; Dongliang Li
Journal:  Front Oncol       Date:  2022-07-11       Impact factor: 5.738

Review 10.  Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow.

Authors:  Fei Xiong; Qi Wang; Guan-Hua Wu; Wen-Zheng Liu; Bing Wang; Yong-Jun Chen
Journal:  Biomark Res       Date:  2022-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.